-+ 0.00%
-+ 0.00%
-+ 0.00%

ANAVEX LIFE SCIENCES ANNOUNCES FULL ENROLLMENT OF PHASE 2 STUDY OF ANAVEX®3-71 FOR THE TREATMENT OF SCHIZOPHRENIA

Reuters·05/01/2025 11:30:00

Please log in to view news